[macksd]

I think the bigger concern in this case is that we don't know. And the overwhelmingly strong historical case for vaccines that exist doesn't really apply that well here since it's a pretty new approach of essentially doing gene therapy to get your own body to produce the protein that triggers the immune response. And as far as I know (and admittedly, my slightly more-than-average time spent researching this still rounds down to nothing) that technique has only been used in humans on a fairly rare disease so far. I'm definitely optimistic from the data so far. I'm more likely to get it since I know I'm done having children anyway. If I was high risk I would probably get it. But I'm not high risk. I'm also optimistic I could survive a COVID-19 infection. I'm not rushing out the door to get my hands on either to be honest.

[dehrmann]

Exactly. This is a new type of vaccine that was rushed through testing being deployed widely for a disease that kills less than 1% of people who get it.